<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
<journal-id journal-id-type="publisher-id">TJP</journal-id>
<journal-id journal-id-type="hwp">jphysiol</journal-id>
<journal-title-group>
<journal-title>The Journal of Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3751</issn>
<issn pub-type="epub">1469-7793</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29333742</article-id>
<article-id pub-id-type="pmc">5878227</article-id>
<article-id pub-id-type="doi">10.1113/JP275393</article-id>
<article-id pub-id-type="publisher-id">TJP12810</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group subj-group-type="heading">
<subject>Editor's Choice</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Parvalbumin fast‐spiking interneurons are selectively altered by paediatric traumatic brain injury</article-title>
<alt-title alt-title-type="left-running-head">J. Nichols and others</alt-title>
<alt-title alt-title-type="right-running-head">Dysfunction of cortical inhibition after paediatric TBI</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="tjp12810-cr-0001">
<name>
<surname>Nichols</surname>
<given-names>Joshua</given-names>
</name>
<xref ref-type="aff" rid="tjp12810-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="tjp12810-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="bio" rid="d35e53">*</xref>
</contrib>
<contrib contrib-type="author" id="tjp12810-cr-0002">
<name>
<surname>Bjorklund</surname>
<given-names>George Reed</given-names>
</name>
<xref ref-type="aff" rid="tjp12810-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp12810-cr-0003">
<name>
<surname>Newbern</surname>
<given-names>Jason</given-names>
</name>
<xref ref-type="aff" rid="tjp12810-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="tjp12810-cr-0004">
<name>
<surname>Anderson</surname>
<given-names>Trent</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3541-7741</contrib-id>
<address>
<email>andersot@email.arizona.edu</email>
</address>
<xref ref-type="aff" rid="tjp12810-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="tjp12810-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">University of Arizona</named-content>
<institution>College of Medicine – Phoenix</institution>
<named-content content-type="city">Phoenix</named-content>
<named-content content-type="country-part">AZ</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp12810-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">School of Life Sciences</named-content>
<institution>Arizona State University</institution>
<named-content content-type="country-part">AZ</named-content>
<country country="US">USA</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold> T. Anderson: University of Arizona, College of Medicine – Phoenix, 425 N 5th St, Phoenix, AZ 85004, USA. Email: <email>andersot@email.arizona.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>4</month>
<year>2018</year>
</pub-date>
<volume>596</volume>
<issue>7</issue>
<issue-id pub-id-type="doi">10.1113/tjp.2018.596.issue-7</issue-id>
<fpage>1277</fpage>
<lpage>1293</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2018 The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:TJP-596-1277.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec id="tjp12810-sec-0010">
<title>Key points</title>
<p>
<list id="tjp12810-list-0001" list-type="bullet"><list-item><p>Traumatic brain injury (TBI) in children remains a leading cause of death and disability and it remains poorly understood why children have worse outcomes and longer recover times.</p></list-item><list-item><p>TBI has shown to alter cortical excitability and inhibitory drive onto excitatory neurons, yet few studies have directly examined changes to cortical interneurons.</p></list-item><list-item><p>This is addressed in the present study using a clinically relevant model of severe TBI (controlled cortical impact) in interneuron cell type specific Cre‐dependent mice.</p></list-item><list-item><p>Mice subjected to controlled cortical impact exhibit specific loss of parvalbumin (PV) but not somatostatin immunoreactivity and cell density in the peri‐injury zone.</p></list-item><list-item><p>PV interneurons are primarily of a fast‐spiking (FS) phenotype that persisted in the peri‐injury zone but received less frequent inhibitory and stronger excitatory post‐synaptic currents.</p></list-item><list-item><p>The targeted loss of PV‐FS interneurons appears to be distinct from previous reports in adult mice suggesting that TBI‐induced pathophysiology is dependent on the age at time of impact.</p></list-item></list>
</p>
</sec>
<sec id="tjp12810-sec-0020">
<title>Abstract</title>
<p>Paediatric traumatic brain injury (TBI) is a leading cause of death and disability in children. Traditionally, ongoing neurodevelopment and neuroplasticity have been considered to confer children with an advantage following TBI. However, recent findings indicate that the paediatric brain may be more sensitive to brain injury. Inhibitory interneurons are essential for proper cortical function and are implicated in the pathophysiology of TBI, yet few studies have directly investigated TBI‐induced changes to interneurons themselves. Accordingly, in the present study, we examine how inhibitory neurons are altered following controlled cortical impact (CCI) in juvenile mice with targeted Cre‐dependent fluorescence labelling of interneurons (<italic>Vgat:Cre/Ai9</italic> and <italic>PV:Cre/Ai6</italic>). Although CCI failed to alter the number of excitatory neurons or somatostatin‐expressing interneurons in the peri‐injury zone, it significantly decreased the density of parvalbumin (PV) immunoreactive cells by 71%. However, <italic>PV:Cre/Ai6</italic> mice subjected to CCI showed a lower extent of fluorescence labelled cell loss. PV interneurons are predominantly of a fast‐spiking (FS) phenotype and, when recorded electrophysiologically from the peri‐injury zone, exhibited intrinsic properties similar to those of control neurons. Synaptically, CCI induced a decrease in inhibitory drive onto FS interneurons combined with an increase in the strength of excitatory events. The results of the present study indicate that CCI induced both a loss of PV interneurons and an even greater loss of PV expression. This suggests caution is required when interpreting changes in PV immunoreactivity alone as direct evidence of interneuronal loss. Furthermore, in contrast to reports in adults, TBI in the paediatric brain selectively alters PV‐FS interneurons, primarily resulting in a loss of interneuronal inhibition.</p>
</sec>
</abstract>
<abstract abstract-type="toc" id="d35e249">
<title>Key points</title>
<p>
<list id="tjp12810-list-0002" list-type="bullet"><list-item><p>Traumatic brain injury (TBI) in children remains a leading cause of death and disability and it remains poorly understood why children have worse outcomes and longer recover times.</p></list-item><list-item><p>TBI has shown to alter cortical excitability and inhibitory drive onto excitatory neurons, yet few studies have directly examined changes to cortical interneurons.</p></list-item><list-item><p>This is addressed in the present study using a clinically relevant model of severe TBI (controlled cortical impact) in interneuron cell type specific Cre‐dependent mice.</p></list-item><list-item><p>Mice subjected to controlled cortical impact exhibit specific loss of parvalbumin (PV) but not somatostatin immunoreactivity and cell density in the peri‐injury zone.</p></list-item><list-item><p>PV interneurons are primarily of a fast‐spiking (FS) phenotype that persisted in the peri‐injury zone but received less frequent inhibitory and stronger excitatory post‐synaptic currents.</p></list-item><list-item><p>The targeted loss of PV‐FS interneurons appears to be distinct from previous reports in adult mice suggesting that TBI‐induced pathophysiology is dependent on the age at time of impact.</p></list-item></list>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="tjp12810-kwd-0001">traumatic brain injury</kwd>
<kwd id="tjp12810-kwd-0002">cortex</kwd>
<kwd id="tjp12810-kwd-0003">pediatric</kwd>
<kwd id="tjp12810-kwd-0004">parvalbumin</kwd>
<kwd id="tjp12810-kwd-0005">interneuron</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Science Foundation</funding-source>
<award-id>IOS‐1353804</award-id>
</award-group>
<award-group>
<funding-source>National Institute of Biomedical Imaging and Bioengineering</funding-source>
<award-id>EB020767</award-id>
</award-group>
<award-group>
<funding-source>National Institute of Neurological Disorders and Stroke</funding-source>
<award-id>NS097537</award-id>
<award-id>NS087031</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="9"></fig-count>
<table-count count="0"></table-count>
<page-count count="17"></page-count>
<word-count count="10488"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>tjp12810</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>1 April 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.4 mode:remove_FC converted:31.03.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group>
<fn id="tjp12810-note-0001">
<p>Edited by: Ole Paulsen &amp; Katalin Toth</p>
</fn>
<fn id="tjp12810-note-0002">
<p>This is an Editor's Choice article from the 1 April 2018 issue.</p>
</fn>
</fn-group>
</notes>
</front>
</article>
</pmc-articleset>